337 related articles for article (PubMed ID: 28159968)
1. Impact of clinical signs and genetic diagnosis of familial hypercholesterolaemia on the prevalence of coronary artery disease in patients with severe hypercholesterolaemia.
Tada H; Kawashiri MA; Nohara A; Inazu A; Mabuchi H; Yamagishi M
Eur Heart J; 2017 May; 38(20):1573-1579. PubMed ID: 28159968
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia.
Khera AV; Won HH; Peloso GM; Lawson KS; Bartz TM; Deng X; van Leeuwen EM; Natarajan P; Emdin CA; Bick AG; Morrison AC; Brody JA; Gupta N; Nomura A; Kessler T; Duga S; Bis JC; van Duijn CM; Cupples LA; Psaty B; Rader DJ; Danesh J; Schunkert H; McPherson R; Farrall M; Watkins H; Lander E; Wilson JG; Correa A; Boerwinkle E; Merlini PA; Ardissino D; Saleheen D; Gabriel S; Kathiresan S
J Am Coll Cardiol; 2016 Jun; 67(22):2578-89. PubMed ID: 27050191
[TBL] [Abstract][Full Text] [Related]
3. Genetic Architecture of Familial Hypercholesterolaemia.
Sharifi M; Futema M; Nair D; Humphries SE
Curr Cardiol Rep; 2017 May; 19(5):44. PubMed ID: 28405938
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetics of familial hypercholesterolemia in Israel-revisited.
Durst R; Ibe UK; Shpitzen S; Schurr D; Eliav O; Futema M; Whittall R; Szalat A; Meiner V; Knobler H; Gavish D; Henkin Y; Ellis A; Rubinstein A; Harats D; Bitzur R; Hershkovitz B; Humphries SE; Leitersdorf E
Atherosclerosis; 2017 Feb; 257():55-63. PubMed ID: 28104544
[TBL] [Abstract][Full Text] [Related]
5. Familial Hypercholesterolemia Genetic Variations and Long-Term Cardiovascular Outcomes in Patients with Hypercholesterolemia Who Underwent Coronary Angiography.
Lee WJ; Chuang HN; Chen YM; Liang KW; Tung H; Chen JP; Lee IT; Wang JS; Lin CH; Lin HJ; Sheu WH; Lee WL; Hsiao TH
Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573395
[TBL] [Abstract][Full Text] [Related]
6. Next-generation-sequencing-based identification of familial hypercholesterolemia-related mutations in subjects with increased LDL-C levels in a latvian population.
Radovica-Spalvina I; Latkovskis G; Silamikelis I; Fridmanis D; Elbere I; Ventins K; Ozola G; Erglis A; Klovins J
BMC Med Genet; 2015 Sep; 16():86. PubMed ID: 26415676
[TBL] [Abstract][Full Text] [Related]
7. The familial hypercholesterolaemia phenotype: Monogenic familial hypercholesterolaemia, polygenic hypercholesterolaemia and other causes.
Mariano C; Alves AC; Medeiros AM; Chora JR; Antunes M; Futema M; Humphries SE; Bourbon M
Clin Genet; 2020 Mar; 97(3):457-466. PubMed ID: 31893465
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein(a) in Familial Hypercholesterolemia With Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Gain-of-Function Mutations.
Tada H; Kawashiri MA; Yoshida T; Teramoto R; Nohara A; Konno T; Inazu A; Mabuchi H; Yamagishi M; Hayashi K
Circ J; 2016; 80(2):512-8. PubMed ID: 26632531
[TBL] [Abstract][Full Text] [Related]
9. Proprotein convertase subtilisin/kexin 9 V4I variant with LDLR mutations modifies the phenotype of familial hypercholesterolemia.
Ohta N; Hori M; Takahashi A; Ogura M; Makino H; Tamanaha T; Fujiyama H; Miyamoto Y; Harada-Shiba M
J Clin Lipidol; 2016; 10(3):547-555.e5. PubMed ID: 27206942
[TBL] [Abstract][Full Text] [Related]
10. Clinical features of familial hypercholesterolemia in Korea: Predictors of pathogenic mutations and coronary artery disease - A study supported by the Korean Society of Lipidology and Atherosclerosis.
Shin DG; Han SM; Kim DI; Rhee MY; Lee BK; Ahn YK; Cho BR; Woo JT; Hur SH; Jeong JO; Jang Y; Lee JH; Lee SH
Atherosclerosis; 2015 Nov; 243(1):53-8. PubMed ID: 26343872
[TBL] [Abstract][Full Text] [Related]
11. Mutation spectrum and polygenic score in German patients with familial hypercholesterolemia.
Rieck L; Bardey F; Grenkowitz T; Bertram L; Helmuth J; Mischung C; Spranger J; Steinhagen-Thiessen E; Bobbert T; Kassner U; Demuth I
Clin Genet; 2020 Nov; 98(5):457-467. PubMed ID: 32770674
[TBL] [Abstract][Full Text] [Related]
12. Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia.
Grenkowitz T; Kassner U; Wühle-Demuth M; Salewsky B; Rosada A; Zemojtel T; Hopfenmüller W; Isermann B; Borucki K; Heigl F; Laufs U; Wagner S; Kleber ME; Binner P; März W; Steinhagen-Thiessen E; Demuth I
Atherosclerosis; 2016 Oct; 253():88-93. PubMed ID: 27596133
[TBL] [Abstract][Full Text] [Related]
13. The impact of gene variants on the thickness and softness of the Achilles tendon in familial hypercholesterolemia.
Michikura M; Hori M; Ogura M; Hosoda K; Harada-Shiba M
Atherosclerosis; 2022 Oct; 358():41-46. PubMed ID: 36087353
[TBL] [Abstract][Full Text] [Related]
14. Familial Hypercholesterolemia Phenotype in Chinese Patients Undergoing Coronary Angiography.
Li JJ; Li S; Zhu CG; Wu NQ; Zhang Y; Guo YL; Gao Y; Li XL; Qing P; Cui CJ; Xu RX; Jiang ZW; Sun J; Liu G; Dong Q
Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):570-579. PubMed ID: 27932355
[TBL] [Abstract][Full Text] [Related]
15. Large-Scale Screening for Monogenic and Clinically Defined Familial Hypercholesterolemia in Iceland.
Björnsson E; Thorgeirsson G; Helgadóttir A; Thorleifsson G; Sveinbjörnsson G; Kristmundsdóttir S; Jónsson H; Jónasdóttir A; Jónasdóttir Á; Sigurðsson Á; Guðnason T; Ólafsson Í; Sigurðsson EL; Sigurðardóttir Ó; Viðarsson B; Baldvinsson M; Bjarnason R; Danielsen R; Matthíasson SE; Thórarinsson BL; Grétarsdóttir S; Steinthórsdóttir V; Halldórsson BV; Andersen K; Arnar DO; Jónsdóttir I; Guðbjartsson DF; Hólm H; Thorsteinsdóttir U; Sulem P; Stefánsson K
Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):2616-2628. PubMed ID: 34407635
[TBL] [Abstract][Full Text] [Related]
16. Oligogenic familial hypercholesterolemia, LDL cholesterol, and coronary artery disease.
Tada H; Kawashiri MA; Nomura A; Teramoto R; Hosomichi K; Nohara A; Inazu A; Mabuchi H; Tajima A; Yamagishi M
J Clin Lipidol; 2018; 12(6):1436-1444. PubMed ID: 30241732
[TBL] [Abstract][Full Text] [Related]
17. Causative mutations and premature cardiovascular disease in patients with heterozygous familial hypercholesterolaemia.
Rubba P; Gentile M; Marotta G; Iannuzzi A; Sodano M; De Simone B; Jossa F; Iannuzzo G; Giacobbe C; Di Taranto MD; Fortunato G
Eur J Prev Cardiol; 2017 Jul; 24(10):1051-1059. PubMed ID: 28353356
[TBL] [Abstract][Full Text] [Related]
18. Genetic diagnosis of familial hypercholesterolaemia using a rapid biochip array assay for 40 common LDLR, APOB and PCSK9 mutations.
Martin R; Latten M; Hart P; Murray H; Bailie DA; Crockard M; Lamont J; Fitzgerald P; Graham CA
Atherosclerosis; 2016 Nov; 254():8-13. PubMed ID: 27680772
[TBL] [Abstract][Full Text] [Related]
19. Widening the spectrum of genetic testing in familial hypercholesterolaemia: Will it translate into better patient and population outcomes?
Page MM; Bell DA; Watts GF
Clin Genet; 2020 Apr; 97(4):543-555. PubMed ID: 31833051
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in the understanding and care of familial hypercholesterolaemia: significance of the biology and therapeutic regulation of proprotein convertase subtilisin/kexin type 9.
Page MM; Stefanutti C; Sniderman A; Watts GF
Clin Sci (Lond); 2015 Jul; 129(1):63-79. PubMed ID: 25881720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]